Can we count your visit with Google Analytics? No ads, no profiles. Details
MRNA
USHealth Care · Biotechnology
Each weekday: the watchlist of pullbacks inside uptrends, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.
Free when you join: the $HOOD Teardown Dossier (Robinhood Markets), the full desk file we sell in the shop. One per new reader.
No spam. One email per day max, unsubscribe in one click. Pro ($49/mo) includes every dossier and report in the shop.
Pure-play mRNA platform in post-COVID rebase. Spikevax revenue stepped down from ~$18B (2022) to mid-single-digit billions and trending lower; mRESVIA launch is early and competes with $PFE Abrysvo + $GSK Arexvy. Cash runway and pipeline conversion (flu, combo, CMV, INT) drive the structural read, not next quarter.
It reads our $MRNA data (thesis, key levels, peers, a year of prices) and any chart screenshot you paste, then explains the setup in plain English. Free with an email login, 5 questions a day. Education only: it never tells you to buy or sell, and it can be wrong, so check the numbers.
High-signal only